NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 50 filers reported holding NEURODERM LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,476,000 | +30.2% | 37,938 | 0.0% | 0.92% | +13.2% |
| Q2 2017 | $1,134,000 | +14.1% | 37,938 | +1.3% | 0.81% | -3.8% |
| Q1 2017 | $994,000 | +18.1% | 37,438 | -1.3% | 0.84% | +13.6% |
| Q4 2016 | $842,000 | +215.4% | 37,921 | +163.0% | 0.74% | +297.8% |
| Q3 2016 | $267,000 | +14.1% | 14,421 | 0.0% | 0.19% | +0.5% |
| Q2 2016 | $234,000 | +1276.5% | 14,421 | +1099.8% | 0.18% | +1133.3% |
| Q1 2016 | $17,000 | – | 1,202 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |